Azacitidine

Product NDC
58458-002
11-digit product format
584580002
Labeler code
58458
Product ID
58458-002_36422686-af0f-a4e1-e063-6294a90a1b44
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Azacitidine
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Labeler
Reliance Life Sciences Private Limited
Application
ANDA217453
Marketing category
ANDA
Marketing start
2025-07-30
Substance
AZACITIDINE
Active strength
100 mg/1
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A217453-001AZACITIDINEAZACITIDINE100MG/VIALPOWDER / INTRAVENOUS, SUBCUTANEOUSAP2025-05-20

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A217453-001AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A217453-001AZACITIDINE100MG/VIALPOWDER / INTRAVENOUS, SUBCUTANEOUSAP2025-05-20caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A217453-001AZACITIDINE100MG/VIALPOWDER / INTRAVENOUS, SUBCUTANEOUSAP2025-05-20011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217453-001AZACITIDINE100MG/VIALPOWDER / INTRAVENOUS, SUBCUTANEOUSAP2025-05-2031067a03dcf5…
2025-08-23 18:47 UTC2025-08A217453-001AZACITIDINE100MG/VIALPOWDER / INTRAVENOUS, SUBCUTANEOUSAP2025-05-206a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A217453-001AZACITIDINE100MG/VIALPOWDER / INTRAVENOUS, SUBCUTANEOUSAP2025-05-20a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A217453-001AP1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A217453-001AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217453-001AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08A217453-001AP16a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A217453-001AP1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Azacitidine
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
AZACITIDINE100 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
M801H13NRUInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
485246Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
5804d999-96eb-4fd1-b7d8-de7867c5f1d6Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0a0a0250-9871-4046-8497-d10e54e52bd8Product name120210510
5cc97977-a1c6-de11-70e0-61007eeef82dProduct name620180820

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
58458-002-02Azacitidine1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,11
58458-002-02Azacitidine1 in 1 VIAL, GLASSINJECTION, POWDER, LYOPHILIZED,11

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AzacitidineAZACITIDINESomerset Therapeutics LLC3bc4f406-2ec7-7169-e063-6394a90a81d92025-08-07Warnings, Adverse reactionsExact identifier
application applno (ANDA): 217453
application number: ANDA217453
AzacitidineAZACITIDINEReliance Life Sciences Private Limited5804d999-96eb-4fd1-b7d8-de7867c5f1d62025-05-29Warnings, Adverse reactionsExact identifier
application applno (ANDA): 217453
application number: ANDA217453
ndc (product): 58458-002

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
485246azaCITIDine 100 MG InjectionPSN5804d999-96eb-4fd1-b7d8-de7867c5f1d61
485246azacitidine 100 MG InjectionSCD5804d999-96eb-4fd1-b7d8-de7867c5f1d61

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
58458-002-02584580002021 VIAL, GLASS in 1 CARTON (58458-002-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS2025-07-30NoNoCurrent